Tagrisso (Osimertinib) TOP Trial Results Why Combination with Chemo is Better.
author-avatar
0 comments
Cancer Medicine, Generic Drugs
02 Jul 2026

Tagrisso (Osimertinib) TOP Trial Results: Why Combination with Chemo is Better.

There have been major developments in terms of treatments for advanced lung cancer. For many years, the only thing patients could rely on was conventional chemotherapy, which helped eliminate cancer cells but induced numerous side effects throughout the body.The breakthrough in precision medicine allowed the situation to change drastically. It...
Continue reading
Why is Tagrisso so Expensive Learn About the Generic Alternatives to Tagrisso
author-avatar
0 comments
Cancer Medicine, Generic Drugs
12 Apr 2025

Why is Tagrisso so Expensive? Learn About the Generic Alternatives to Tagrisso

In the last decade, lung cancer has advanced significantly, offering new hope to patients. The discovery of Osimertinib and its benefit in treating lung cancer is an important step towards improving survival rates. Developed by AstraZeneca under the brand name Tagrisso, has been a game-changer in improving survival rates, but...
Continue reading
author-avatar
0 comments
Cancer Medicine
20 Mar 2025

Osimertinib Side Effects: Common, Severe, and Long-Term Risks You Should Know

Doctors often prescribe Osimertinib to treat lung cancer associated with specific EGFR (epidermal growth factor receptor) mutations. However, its effects extend beyond this targeted treatment. While some Osimertinib side effects are mild, temporary, and resolve on their own, others can be more severe or persistent. Some issues may appear early,...
Continue reading
author-avatar
0 comments
Generic Drugs, Cancer Medicine
01 Jan 2025

Cabozantinib Generic vs. Brand: Whats the Difference in Cost and Efficacy?

Cancer treatment can be challenging and expensive. One crucial medication used to treat several types of cancers is Cabozantinib. It works best for patients with kidney and liver cancer. This drug is available in generic and FDA-approved brand versions that doctors prescribe as cancer medications. Cabometyx - Used for renal cell carcinoma...
Continue reading
author-avatar
0 comments
Cancer Medicine, FDA Approval and Clinical Trials
30 Aug 2024

Osimertinib as a First-Line Therapy: Key Approvals and Benefits for Lung Cancer Patients

Osimertinib, a revolutionary drug in treating EGFR-mutant non-small cell lung cancer (NSCLC), is making waves in oncology. Osimertinib, also known as Tagrisso. Developed initially as a second-line treatment for patients with resistant forms of lung cancer, Osimertinib has gained importance as a first-line therapy in recent years. With its ability to...
Continue reading
Load more posts
Loading...